Header Logo

Connection

HUBERT HSING CHUANG to Lymphoma, Mantle-Cell

Back to Details
This is a "connection" page, showing publications HUBERT HSING CHUANG has written about Lymphoma, Mantle-Cell.
HUBERT HSING CHUANG
Connection Strength
0.090
Lymphoma, Mantle-Cell
  1. Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trial. Lancet Oncol. 2016 Jan; 17(1):48-56.
    View in: PubMed
    Score: 0.090
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.